Ade Lawal Joins Aspyra as Vice President of Strategy and Business Development
10 6월 2008 - 9:30PM
Business Wire
Aspyra, Inc. (AMEX: APY), a leading provider of clinical and
diagnostic information solutions for the healthcare industry, today
announced Ade Lawal has joined the Company as Vice President of
Strategy and Business Development. Mr. Lawal brings with him over a
decade of experience in consulting and operations management, most
recently as Director of Service for GE Healthcare. Having attained
the Lean Six Sigma Black Belt certification from GE Healthcare, Mr.
Lawal has successfully implemented various operational and
service-oriented improvement efficiencies for the healthcare
business environment. His efforts resulted in number one customer
satisfaction rating within GE based on Net Promoter Score for
southern California, and service revenue growth of three times the
industry average. Prior to GE, Mr. Lawal worked as Senior
Consultant for KPMG Consulting. He holds an MBA from Harvard
Business School, Bachelor of Science from University of Virginia
and is also a Certified Public Accountant. Ade Lawal commented, �In
addition focusing on customer satisfaction and internal process
improvements, I plan on contributing to the top line growth by
working with sales and marketing to build business relationships
with strategic partners that further promote Aspyra as a leader in
the healthcare industry.� He continued, �I am excited to be part of
Aspyra as we take the Company forward.� Aspyra CEO, Jim Zierick
stated, �With Ade�s experience in service operations and customer
satisfaction, his responsibilities at Aspyra will include working
with various members of management to implement quality service
initiatives and metrics that improve our business efficiencies and
costs. These initiatives are part of the building blocks that will
help scale the business for profitable growth.� Aspyra solutions
provide integrated technologies and services that improve the
efficiency, safety and quality of patient care. Aspyra works
directly with customers through its own sales and service staff as
well as through an extensive partner network. The Company currently
counts over 440 customers and over 650 application installations in
its installed base. About Aspyra Aspyra is a global provider of
Health Care Information Technology (HCIT) solutions and services to
the healthcare industry. The Company specializes in Clinical
Information Systems (CIS), Picture Archive Communication Systems
(PACS) and Clinical Image Management Systems (CIMS) for hospitals,
multi-specialty clinics, clinical laboratories, imaging departments
and centers and orthopedic environments. Aspyra's highly scalable
systems can be installed standalone or integrated to provide a
single-vendor, enterprise-wide solution. For more information on
Aspyra, its products and services, visit www.aspyra.com. Safe
Harbor Statement This press release includes forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995. Forward-looking statements are not guarantees
of future performance and are inherently subject to uncertainties
and other factors which could cause actual results to differ
materially from the forward-looking statement. Such statements are
based upon, among other things, assumptions made by, and
information currently available to, management as of the date of
this release, including management's own knowledge and assessment
of the Company's industry, customers and competition. Factors that
could cause Aspyra's actual results to differ materially from these
forward-looking statements include among others: changes in the
Company�s management or other personnel, the competitive
environment for Company products and services; unexpected technical
and marketing difficulties inherent in major product development
efforts; the potential need for changes in the Company�s long-term
strategy in response to future developments; future advances in
clinical information technology and procedures, as well as
potential changes in government regulations and healthcare
policies; and rapid technological change in the microelectronics
and software industries. The Company refers interested persons to
its most recent Annual Report on Form 10-KSB and its other SEC
filings for a description of additional uncertainties and factors,
which may affect forward-looking statements. The Company assumes no
duty to update its forward-looking statements.
Aspyra (AMEX:APY)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025
Aspyra (AMEX:APY)
과거 데이터 주식 차트
부터 1월(1) 2024 으로 1월(1) 2025
Aspyra, (아메리카 증권거래소)의 실시간 뉴스: 최근 기사 0
More Aspyra, Inc. News Articles